BSE Live
Nov 03, 16:01Prev. Close
350.55
Open Price
335.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Trident Texofab (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 2.38 | 1.07 | 2.20 | 0.98 | 0.35 | |
| Diluted EPS (Rs.) | 2.09 | 1.07 | 2.20 | 0.98 | 0.35 | |
| Cash EPS (Rs.) | 3.07 | 2.71 | 3.84 | 2.43 | 1.37 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 34.84 | 16.14 | 15.07 | 12.87 | 11.89 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 34.84 | 16.14 | 15.07 | 12.87 | 11.89 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 90.02 | 98.79 | 95.69 | 83.71 | 49.58 | |
| PBDIT/Share (Rs.) | 6.47 | 6.50 | 8.15 | 5.49 | 4.70 | |
| PBIT/Share (Rs.) | 5.26 | 4.86 | 6.52 | 4.03 | 3.69 | |
| PBT/Share (Rs.) | 1.90 | 1.16 | 2.71 | 1.26 | 0.90 | |
| Net Profit/Share (Rs.) | 1.85 | 1.07 | 2.20 | 0.98 | 0.35 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 7.18 | 6.57 | 8.52 | 6.55 | 9.48 | |
| PBIT Margin (%) | 5.83 | 4.92 | 6.81 | 4.81 | 7.43 | |
| PBT Margin (%) | 2.11 | 1.17 | 2.82 | 1.51 | 1.81 | |
| Net Profit Margin (%) | 2.05 | 1.08 | 2.30 | 1.16 | 0.70 | |
| Return on Networth / Equity (%) | 5.31 | 6.64 | 14.61 | 7.58 | 2.94 | |
| Return on Capital Employed (%) | 11.91 | 12.35 | 16.38 | 9.96 | 9.89 | |
| Return on Assets (%) | 2.49 | 1.31 | 2.86 | 1.38 | 0.52 | |
| Total Debt/Equity (X) | 0.56 | 2.27 | 2.28 | 2.78 | 2.43 | |
| Asset Turnover Ratio (%) | 1.34 | 1.25 | 1.30 | 1.21 | 0.81 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.81 | 1.23 | 1.25 | 1.32 | 1.32 | |
| Quick Ratio (X) | 1.42 | 0.91 | 0.97 | 1.08 | 1.06 | |
| Inventory Turnover Ratio (X) | 8.27 | 1.62 | 2.63 | 1.87 | 0.58 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 260.35 | 85.97 | 92.54 | 98.28 | 55.04 | |
| EV/Net Operating Revenue (X) | 2.13 | 0.86 | 0.96 | 1.17 | 1.10 | |
| EV/EBITDA (X) | 29.68 | 13.14 | 11.27 | 17.78 | 11.63 | |
| MarketCap/Net Operating Revenue (X) | 1.94 | 0.49 | 0.60 | 0.74 | 0.52 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 5.02 | 3.02 | 3.82 | 4.81 | 2.17 | |
| Price/Net Operating Revenue | 1.94 | 0.49 | 0.60 | 0.74 | 0.52 | |
| Earnings Yield | 0.01 | 0.02 | 0.04 | 0.02 | 0.01 | 
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017